All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.
Bookmark this article
ASCO Annual Meeting, 1-5 June 2018, Chicago, IL
Perlmutter Cancer Center, NYU Langone Health, New York, US
Interview topic: Novel therapies for R/R HL beyond transplant
Catherine Diefenbach | ASCO 2018 | Novel therapies for R/R HL beyond transplant
Understanding your specialty helps us to deliver the most relevant and engaging content.
Please spare a moment to share yours.
Please select or type your specialty
Your opinion matters
Catherine Diefenbach | ASH 2018 | New checkpoint blockade therapy from China with interesting data
Catherine Diefenbach, from NYU Perlmutter Cancer Center, discusses new checkpoint blockade therapy data.
Loretta Nastoupil | ASCO 2018 | Overview of checkpoint inhibitors in Lymphoma
Loretta Nastoupil at ASCO 2018 Overview of checkpoint inhibitors in Lymphoma
Subscribe to get the best content related to lymphoma & CLL delivered to your inbox